Best Strategies to Assess Advanced Fibrosis in MASLD

Mi Na Kim (Yonsei Univ.)

Use of Anti-Diabetic Drugs in MASLD: Can We Kill Two Birds with One Stone?

Joonyub Lee (The Catholic Univ. of Korea)

Relationship between MASLD and Chronic Hepatitis B: Friends or Foes

Shang-Chin Huang (National Taiwan Univ., Taiwan)

Discussion

Mi Na Kim (Yonsei Univ.), Joonyub Lee (The Catholic Univ. of Korea), Shang-Chin Huang (National Taiwan Univ., Taiwan)

Practical Tips for Designing and Conducting Successful RCT

Sumeet Asrani (Baylor Univ., USA)

Biases, Challenges, and Innovations in RCT Statistics

Inkyung Jung (Yonsei Univ.)

Successes and Failures in RCT: Insights from AASLD Experiences

Kris V. Kowdley (Washington State Univ., USA)

Successes and Failures in RCT: Insights from KASL Experiences

Young-Suk Lim (Univ. of Ulsan)

HBV with Co-Existing Liver Diseases: The Interactions between Viral Hepatitis C, MAFLD, and HBV

Chun-Jen Liu (National Taiwan Univ., Taiwan)

CXCR4+ CD8+ T Cells in Alcoholic Liver Disease: Enhanced Cytotoxicity and Associations with Liver Function Markers

Pil Soo Sung (The Catholic Univ. of Korea)

Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Hepatocellular Carcinoma: 9-Year Extended Follow-Up of a Randomized Controlled Trial and Post-Treatment Immune Cell Profiling

Hyunjae Shin (Seoul National Univ.)

Surgical Quality Assessment with Artificial Intelligence-Based Video Analysis for Laparoscopic Donor Right Hemihepatectomy: Usefulness of Round Ligament Fixation in Hilar Structure Dissection

Dai Hoon Han (Yonsei Univ.)

Performance of Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma: A Network Meta-Analysis

Yeongseok Hwang (Univ. of Ulsan)

Pipelines for Curing Hepatitis B Using Immunological Targets: Successes and Failures

Won-Mook Choi (Univ. of Ulsan)

Targeting Innate Immunity as a Promising Approaches for Curing Hepatitis B

Loey Lung-Yi Mak (The Univ. of Hong Kong, Hong Kong)

Targeting Adaptive Immunity as a Promising Approaches for Curing Hepatitis B

Markus Cornberg (Hannover Medical School, Germany)

Development of a Novel Immune Modulator SA-5 as a Therapeutic Option for Chronic Hepatitis B

Tatsuya Kanto (Japan Institute for Health Security, Japan)

Etiology-Based Primary Prevention Strategies for Hepatocellular Carcinoma

Jeong Han Kim (Konkuk Univ.)

Post-Resection Monitoring and Predictors for Hepatocellular Carcinoma Recurrence

Min-Su Park (Kyung Hee Univ.)

Diagnosis and Multidisciplinary Management of Recurrent Hepatocellular Carcinoma after Hepatectomy

Hye Won Lee (Yonsei Univ.)

Criteria and Workups for Liver Transplant Eligibility in Recipients Focus on Hepatocellular Carcinoma Patients

Seok-Hwan Kim (Chungnam National Univ.)

Trends from the Nationwide Cancer Registry

Han Ah Lee (Chung-Ang Univ.)

Future Trends in HCC Epidemiology in Korea

Young Eun Chon (CHA Univ.)

Imaging and Beyond: Expanding HCC Surveillance Modalities

Hyuk Soo Eun (Chungnam National Univ.)

The Future of Imaging-Based HCC Surveillance: Personalized Approaches and Artificial Intelligence

Hyo Jung Park (Univ. of Ulsan)

The Role of Liver Biopsy in Hepatocellular Carcinoma Management: A KLCA Perspective

Hae Lim Lee (The Catholic Univ. of Korea)

Liquid vs. Tissue Biopsy to Support Treatment Decisions in HCC

Soung Won Jeong (Soonchunhyang Univ.)

Artificial Intelligence-Based Pathology as a Biomarker of Sensitivity to Immunotherapy

Sung Hak Lee (The Catholic Univ. of Korea)

Strategies to Effectively Drive the Cancer-Immunity Cycle: Roles of Each Therapeutic Modality in Hepatocellular Carcinoma

Hideki Iwamoto (Kurume Univ., Japan)

Mechanisms of Metastasis Revealed through Single-Cell Spatial Transcriptome Analysis in Patients with Liver Metastatic Colorectal Cancer

Jungmin Choi (Korea Univ.)

Pre-Transplant HCC Control: Surgical Resection and Bridging Strategies

Jongman Kim (Sungkyunkwan Univ.)

Innovative Bridging Therapies for HCC: From Transarterial Chemoembolization to Immune Checkpoint Inhibitors

Tomoharu Yamada (The Univ. of Tokyo, Japan)

Post-Transplant HCC Recurrence: Predictors, Surveillance, and Novel Interventions

Soon Sun Kim (Ajou Univ.)

Immunosuppression and Immunotherapy in Post-Liver Transplant HCC: Striking the Right Balance

Tomoharu Yoshizumi (Kyushu Univ., Japan)

High-Grade Morbid Obesity

Unenbat Gurbadam (National Cancer Center, Mongolia)

Severe Cardiovascular Disease

Haeil Jung (Soonchunhyang Univ.)

Elderly Patients over 75 Years

Etsuro Hatano (Kyoto Univ., Japan)

End-Stage Renal Disease

Chan Woo Cho (Yeungnam Univ.)

Technical Differences in Surgical Approaches

Dai Hoon Han (Yonsei Univ.)

Challenges and Learning Curve for Beginners

Su Young Hong (Seoul National Univ.)

Clinical Outcomes and Complications: Laparoscopic vs. Robotic Liver Resection

Kwan Woo Kim (Dong-A Univ.)

Open Liver Resection as a Good Surgical Approach: Indications and Outcomes

Kwangho Yang (Pusan National Univ.)

Percutaneous Liver Biopsy: When to Decide to Perform and How to Minimize Risk

Hyeon Ji Jang (Univ. of Ulsan)

Management of Hospitalized Patients with Alcohol Withdrawal Syndrome

Jae Hyun Yoon (Chonnam National Univ.)

Inpatient Care for Gastrointestinal Bleeding in Patients with Liver Cirrhosis

Heechul Nam (The Catholic Univ. of Korea)

Precipitating Factors and Management of Hepatic Encephalopathy

Jae Seung Lee (Yonsei Univ.)

Alcohol Dependence and Liver Transplantation: The Importance of Mental Health Care

Kye-Seong Lee (Incheon Chamsarang Hospital)

Liver Transplantation for Alcohol-Associated Liver Disease: Surgical Perspective and Prognosis

Hae Won Lee (Seoul National Univ.)

Coordination of the Liver Transplant Process and Patient Management for Alcoholic Liver Disease: Evolving Roles of Transplant Coordinators in Korea

Sunyoung Son (Gangnam Severance Hospital)

Social Support and Rehabilitation for Liver Transplant Patients with Alcohol-Associated Liver Disease

Eunseon Suh (Hwaseong Community Addiction Management Center)

Minimal Invasive Surgery for Intrahepatic Cholangiocarcinoma

Kyeong Deok Kim (Inha Univ.)

Extent of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma

Poowanai Sarkhampee (Sunpasitthiprasong Hospital, Thailand)

Surgical Approaches for Hilar Cholangiocarcinoma

Sang Hwa Song (Chonnam National Univ.)

Role of Liver Transplantation in the Treatment of Intrahepatic Cholangiocarcinoma

Amit Singal (UT Southwestern Medical Center, USA)

Challenges in the Diagnosis and Treatment of Autoimmune Hepatitis

Soon Kyu Lee (The Catholic Univ. of Korea)

Current Status and Research Trends of Autoimmune Liver Diseases in Japan

Atsushi Tanaka (Teikyo Univ., Japan)

Updates in Diagnosis and Management of Rare Vascular Liver Diseases

Yu Rim Lee (Kyungpook National Univ.)

Primary Hemostasis in Cirrhosis: A Modern Perspective on Coagulopathy

Manoj Kumar Sharma (Institute of Liver and Biliary Sciences, India)

Metabolomic Biomarkers for Risk Stratification and Prognosis Prediction in Cirrhotic Patients

Eun Ju Cho (Seoul National Univ.)

Recompensation in Cirrhosis: Mechanisms, Predictors, and Therapeutic Strategies

Byeong Geun Song (Sungkyunkwan Univ.)

Treatment of Portal Hypertension in Patients with Hepatocellular Carcinoma in the Era of Baveno VII

Dominique Damais-Thabut (Sorbonne Univ., France)

Integration of Clinical, Computational, and Genomic Resources for Early HCC Detection

Augusto Villanueva (NYU Langone, USA)

Molecular Insights into HCC Recurrence from Minimal Residual Disease after Therapy

Renumathy Dhanasekaran (Stanford Univ., USA)

Immune Microenvironment and Therapeutic Discovery in HCC Using Single-Cell Omics Analysis

Valerie Chew (Duke-NUS Medical School, Singapore)

Genomic Characteristics of RB1-Deficient HCC and Its Therapeutic Candidates

Ju Hyun Shim (Univ. of Ulsan)

Comparison of Liver Fibrosis Assessment Using VCTE versus SWE

Moon Hyung Lee (Kyung Hee Univ.)

The Role of Ultrasound in the Diagnosis and Assessment of MASLD

Heejoon Jang (Seoul National Univ.)

Outcome Prediction Using Ultrasound in Chronic Liver Diseases

Jun Sik Yoon (Inje Univ.)

Discussion

Tune-In Session

Opening Remark

Case 1. Enhancing Survival with IO + Anti-VEGF
The Role of Combination Therapy in Achieving an Earlier Impact on Patient Outcomes

Hideki Iwamoto (Kurume Univ., Japan)

Polling and Discussion

Case 2. Preserving Liver Function with Early-Stage Treatment
The Importance of Timely Intervention and MDT Collaboration, with Insights from TACE-R and TACE-U Cases

Jacob George (The Univ. of Sydney, Australia)

Polling and Discussion

Closing Remark

IO-Based Combinations in Advanced Hepatocellular Carcinoma: Real-World STRIDE Experience and Clinical Impact on Unmet Needs

Amit Singal (UT Southwestern Medical Center, USA)

Discussion

Tenofovir: Early Treatment Marks the Beginning of a Cure for Chronic Hepatitis B

Jeong Heo (Pusan National Univ.)

Percutaneous Liver Biopsy: When to Decide to Perform and How to Minimize Risk

Hyeon Ji Jang (Univ. of Ulsan)

Management of Hospitalized Patients with Alcohol Withdrawal Syndrome

Jae Hyun Yoon (Chonnam National Univ.)

Inpatient Care for Gastrointestinal Bleeding in Patients with Liver Cirrhosis

Heechul Nam (The Catholic Univ. of Korea)

Precipitating Factors and Management of Hepatic Encephalopathy

Jae Seung Lee (Yonsei Univ.)

Advanced Survival Analysis

Woojoo Lee (Seoul National Univ.)

Development and Evaluation of Clinical Prediction Models

Sehee Kim (Univ. of Ulsan)

Differences between Sponsor-Initiated Trials and Investigator-Initiated Trials

Minjong Lee (Ewha Womans Univ.)

Human Subjects Protection and Data Review Board

Seungwon Jeung (Korea Health Information Service)

Collection and Management of Patient-Derived Samples in Clinical Trials

Dae Won Jun (Hanyang Univ.)

Keywords for Investigator-Initiated Trials (IIT): What Academia Needs to Know

Elisabet Kim (Asan Medical Center)

Tracing Cellular Dynamics during Intestinal Tumorigenesis and Metastasis

Min Kyu Yum (KAIST)

Histone Lactylation: A Novel Epigenetic Mark in Liver Fibrosis

Hyunsoo Rho (Ewha Womans Univ.)

Casp2: The New Hepatic Lipid Regulator

Ju Youn Kim (Hanyang Univ.)

Identification of Novel Targets for the Treatment of MASLD

Keon Wook Kang (Seoul National Univ.)

Current Status and Unmet Need of Reimbursement of Systemic Chemotherapy for HCC

Eileen L. Yoon (Hanyang Univ.)

Procedural Standards for Health Insurance Coverage and Criteria for Oncology Drug Reimbursement

Mi Young Kang (Health Insurance Review and Assessment Service)

Introduction of National Hepatitis C Screening and Post-Screening Management Plan

Young Joon Park (Korea Disease Control and Prevention Agency)

Disease Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease and Management of High-Risk Groups in Korea

Won-Ho Kim (Korea National Institute of Health)